Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This study will compare medical therapy plus stenting of hemodynamically significant renal
artery stenoses versus medical therapy alone in patients with systolic hypertension and renal
artery stenosis.
Phase:
Phase 3
Details
Lead Sponsor:
Baim Institute for Clinical Research Harvard Clinical Research Institute
Collaborator:
Beth Israel Deaconess Medical Center
Treatments:
Amlodipine, atorvastatin drug combination Candesartan Candesartan cilexetil